Poland – Pharmaceutical products – Zakup i dostawy leków - programy lekowe

The subject of this order is the purchase and delivery of medicines – drug programmes according to the estimated quantities specified in Annex No. 1 to the SWZ, divided into 18 parts, which is an integral part of this specification: Package 1 – Glatiramer acetate – Drug Programme B29 – Treatment of multiple sclerosis Package 2 – Interferon beta – 1a – Drug Programme B29 – Treatment of multiple sclerosis Package 3 – Interferon beta – 1b – Drug Programme B29 – Treatment of multiple sclerosis Package 4 – Dimethyl fumarate – Drug Programme B29 – Treatment of multiple sclerosis Package 5 – Peginterferon beta – 1a – Drug Programme B29 – Treatment of multiple sclerosis Package 6 – Siponimod 0,25mg – Drug Programme B29 – Treatment of multiple sclerosis Package 7 – Siponimod 1mg – Drug Programme B29 – Treatment of multiple sclerosis Package 8 – Siponimod 2mg – Drug Programme B29 – Treatment of multiple sclerosis Package 9 – Oftamumab – Drug Programme B29 – Treatment of multiple sclerosis Package 10 – Teriflunamide – Drug Programme B29 – Treatment of multiple sclerosis Package 11 – Ocrelizumab – Drug Programme B29 – Treatment of multiple sclerosis Package 12 – Ozanimod – Drug Programme B29 – Treatment of multiple sclerosis Package 13 – Human immunoglobulin – Drug Programme B67 – Immunoglobulin treatment of neurological diseases Package 14 – Aflibercept 40mg – Drug Programme B70 – Treatment of patients with retinal diseases Package 15 – Aflibercept 114,3mg – Drug Programme B70 – Treatment of patients with retinal diseases Package 16 – Brolucizumab – Drug Programme B70 – Treatment of patients with retinal diseases Package 17 – Faricimab – Drug Programme B70 – Treatment of patients with retinal diseases Package 18 – Cinacalcet – Drug Programme B39 – Treatment of secondary hyperparathyroidism in patients undergoing dialysis